Moderna Inc will apply for emergency clearance from the US and Europe for its Covid-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective without serious safety concerns, the company said. Moderna also reported that its vaccine’s efficacy rate was consistent based on age, …
Read More »